Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

01:00pm, Wednesday, 11'th May 2022 Zacks Investment Research
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Raymond James has decided to maintain its Outperform rating of Hologic (NASDAQ:HOLX) and lower its price target from $84.00 to $83.00. Shares of Hologic are trading down 2.08% over the last 24 hours,
Hologic Inc (NASDAQ: HOLX) reported Q2 FY22 sales of $1.44 billion, down 7% Y/Y, and beating the consensus Wall Street estimate for revenues of $1.29 billion. Lower sales of COVID-19 assays primaril
Hologic's (HOLX) second-quarter 2022 revenues decline year over year primarily due to lower COVID-19 assay sales compared to the prior year.
Steve MacMillan, the CEO of medical technology company Hologic, warned that the global semiconductor chip shortage “impacts women's health.”

Hologic (HOLX) Q2 2022 Earnings Call Transcript

01:30am, Thursday, 28'th Apr 2022 The Motley Fool
HOLX earnings call for the period ending March 31, 2022.
Hologic, Inc. (NASDAQ:HOLX ) Q2 2022 Earnings Conference Call April 27, 2022 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and C

Hologic (HOLX) Q2 Earnings and Revenues Surpass Estimates

09:15pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Hologic (HOLX) delivered earnings and revenue surprises of 33.55% and 12.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Hologic (HOLX) delivered earnings and revenue surprises of 33.55% and 12.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Hologic (HOLX) This Earnings Season?

11:31am, Tuesday, 26'th Apr 2022 Zacks Investment Research
Hologic (HOLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Hologic (HOLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Expert Ratings for Hologic

02:24pm, Monday, 25'th Apr 2022 Benzinga
Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 3 0 0 Last 30
Upgrades RBC Capital upgraded the previous rating for United States Steel Corp (NYSE:X) from Sector Perform to Outperform. United States Steel earned $3.64 in the fourth quarter, compared to $0.27 in

DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?

01:46pm, Monday, 25'th Apr 2022 Zacks Investment Research
DexCom's (DXCM) first-quarter results are likely to reflect rising global awareness of its real-time CGM.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE